Division of Hospital Medicine, Valley Children's Healthcare, Madera, California
Division of Hospital Medicine, Valley Children's Healthcare, Madera, California.
Hosp Pediatr. 2021 Aug;11(8):e133-e141. doi: 10.1542/hpeds.2021-005919. Epub 2021 May 19.
Define the spectrum of disease in pediatric inpatients with a positive SARS-CoV-2 test result in a manner relevant to pediatric hospital medicine.
Retrospective case series of all patients aged <22 years hospitalized at our institution with a positive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) polymerase chain reaction test result between May 1, 2020, and September 30, 2020. Demographic, clinical, and outcome data were collected and analyzed.
Three distinct presentations were associated with acute SARS-CoV-2 positivity. Patients had incidental infection (40%), were potentially symptomatic (47%), or were significantly symptomatic (14%). The average length of stay differed between the significantly symptomatic group and the incidental and potentially symptomatic groups ( =.002). Average age differed among these groups, with significantly symptomatic patients older by >2 years. Fifty-five percent of incidental and 47% of potentially symptomatic patients had at least 1 identified comorbidity, whereas 90% of significantly symptomatic patients had at least 1 ( = .01). There was a significant relationship between obesity ( = .001) and asthma ( = .004) and severe disease. Additionally, there was a statistically significant difference between groups with respect to fever, hypoxia, supplemental oxygen use, duration of supplemental oxygen, and ICU admission, with a significantly higher percentage of patients in the significantly symptomatic group meeting each of these criteria ( < .001 for all categories).
Pediatric patients hospitalized with SARS-CoV-2 fall into distinct categories, which are critical to understanding the true pathology of SARS-Cov-2 as it relates to hospitalized pediatric patients. Most hospitalized patients who test positive for SARS-CoV-2 are asymptomatic or have a reason for hospitalization other than coronavirus disease 2019.
以与儿科医院医学相关的方式定义儿科住院患者 SARS-CoV-2 检测阳性的疾病谱。
对 2020 年 5 月 1 日至 9 月 30 日期间在我院住院且 SARS-CoV-2 聚合酶链反应检测结果为阳性的所有年龄<22 岁的患者进行回顾性病例系列研究。收集并分析人口统计学、临床和结局数据。
急性 SARS-CoV-2 阳性与三种不同的表现相关。患者为偶然感染(40%)、可能有症状(47%)或明显有症状(14%)。明显有症状组与偶然感染组和可能有症状组之间的平均住院时间不同( =.002)。这些组之间的平均年龄不同,明显有症状的患者年龄大 2 岁以上。55%的偶然感染和 47%的可能有症状的患者至少有一种合并症,而 90%的明显有症状的患者至少有一种( =.01)。肥胖( =.001)和哮喘( =.004)与重症疾病之间存在显著关系。此外,各组之间在发热、缺氧、使用补充氧气、补充氧气持续时间和 ICU 入院方面存在显著差异,明显有症状组中符合这些标准的患者比例明显更高(所有类别均<.001)。
因 SARS-CoV-2 住院的儿科患者分为不同类别,这对于理解 SARS-CoV-2 与住院儿科患者相关的真正病理学至关重要。大多数 SARS-CoV-2 检测阳性的住院患者无症状或因其他疾病住院,而不是 2019 年冠状病毒病。